Edition:
United States

Luminex Corp (LMNX.OQ)

LMNX.OQ on NASDAQ Stock Exchange Global Select Market

19.84USD
20 Feb 2018
Change (% chg)

-- (--)
Prev Close
$19.84
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
82,007
52-wk High
$22.41
52-wk Low
$17.68

Chart for

About

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease... (more)

Overall

Beta: 0.14
Market Cap(Mil.): $874.04
Shares Outstanding(Mil.): 44.05
Dividend: 0.06
Yield (%): 1.21

Financials

  Industry Sector
P/E (TTM): -- 31.53 17.28
EPS (TTM): -- -- --
ROI: -- 9.24 35.61
ROE: -- 13.60 17.17

BRIEF-Luminex Corp Reports Q4 GAAP Loss Per Share $0.07

* ORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS

Feb 12 2018

BRIEF-Luminex Corporation receives FDA clearance for Aries Group A Strep Assay

* Luminex Corporation receives FDA clearance for Aries Group A Strep Assay Source text for Eikon: Further company coverage:

Oct 31 2017

BRIEF-Luminex Corp reports Q3 earnings per share $0.40

* Luminex Corporation reports third quarter 2017 financial results

Oct 30 2017

BRIEF-Zicom Group says settlement agreement has been reached​ on ‍lawsuit filed by Luminex Corporation against Curiox Biosystems

* Refers to ‍lawsuit filed by luminex corporation against curiox biosystems; advises settlement agreement has been reached​ Source text for Eikon: Further company coverage:

Oct 25 2017

BRIEF-Luminex Corp - Labcorp agrees to extend commitment to Luminex Cystic Fibrosis

Sept 12 Laboratory Corporation Of America Holdings

Sep 11 2017

BRIEF-Zicom Group updates on litigation against Curiox Biosystems Inc​

* ‍Luminex Corporation has filed an original complaint against Curiox Biosystems Inc​

Sep 04 2017

Competitors

Earnings vs. Estimates